Review





Similar Products

96
Proteintech anti calnexin primary antibody
Anti Calnexin Primary Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2+ap/Calnexin+Antibody/pmc13744489-78-29-32
Average 96 stars, based on 1 article reviews
anti calnexin primary antibody - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

97
Proteintech anti cleaved caspase 3
H&E staining of tumor tissues on day 7 after irradiation: (a) CK group; yellow arrow: densely arranged tumor cells. (b) BNCTN20 group; white arrows: apoptotic cells; red arrow: stromal congestion; black arrow: inflammatory cell infiltration. (c–e) <t>Cleaved</t> <t>caspase-3</t> immunohistochemical staining and quantitative analysis (brown-yellow indicates positive signal; blue indicates hematoxylin-counterstained nuclei; expressed as IOD/Area).
Anti Cleaved Caspase 3, supplied by Proteintech, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2+ap/Caspase+3%2Fp17%2Fp19+Antibody/bio_rxiv__64898__2026__11__04__764456-48-29-31
Average 97 stars, based on 1 article reviews
anti cleaved caspase 3 - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

95
SouthernBiotech anti human igg f ab 2
Effect of multimerization on B cell activation (A) Schematic showing top-down views of HIV-1 Env trimer with binding sites for three different Fabs on the gp120 subunit. 2G12: high mannose glycan clusters, CH31: CD4 binding site, and CH01: targeting quaternary epitope on trimer apex. See also  and  and  .  (B) Calcium flux (Ca2+ flux) responses in Ramos cells expressing CH31 IgM B cell receptors by the monomeric (orange) and tetrameric (blue) forms of B42A monomer. See also  and  .  (C) Activation (Ca2+ flux) of Ramos cells expressing 2G12 IgG B cell receptors by B42A monomer (orange) and tetramer (red) as well as B37B monomer (green) and tetramer (blue). (D) Ca2+ flux responses of Ramos cells expressing the 2G12 IgM B cell receptor by CAP256 Trimer  ,  (orange) and its multimerized (8-mer) form (blue).  (E) Ca2+ flux responses of Ramos cells expressing the V2 apex-specific CH01.UCA B cell receptor by CAP256 Trimer (orange) and its multimerized (8-mer) form (blue). All Ramos cells were treated with either HIV-1 Env trimer or HIV-1 gp120 antigens and monitored for intracellular Ca2+ binding dye fluorescence for 300s. Ca2+ flux results for the Ramos cells are presented as a percentage of the maximum anti-human IgM or IgG F(ab′) 2 response and are an average of at least two measurements.
Anti Human Igg F Ab 2, supplied by SouthernBiotech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2+ap/Goat+Anti-Human+IgG+Fc-AP/pmc13755956-490-17-21
Average 95 stars, based on 1 article reviews
anti human igg f ab 2 - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
Thermo Fisher n 2 hydroxyethylpiperazine n 2 ethane sulfonic acid
Effect of multimerization on B cell activation (A) Schematic showing top-down views of HIV-1 Env trimer with binding sites for three different Fabs on the gp120 subunit. 2G12: high mannose glycan clusters, CH31: CD4 binding site, and CH01: targeting quaternary epitope on trimer apex. See also  and  and  .  (B) Calcium flux (Ca2+ flux) responses in Ramos cells expressing CH31 IgM B cell receptors by the monomeric (orange) and tetrameric (blue) forms of B42A monomer. See also  and  .  (C) Activation (Ca2+ flux) of Ramos cells expressing 2G12 IgG B cell receptors by B42A monomer (orange) and tetramer (red) as well as B37B monomer (green) and tetramer (blue). (D) Ca2+ flux responses of Ramos cells expressing the 2G12 IgM B cell receptor by CAP256 Trimer  ,  (orange) and its multimerized (8-mer) form (blue).  (E) Ca2+ flux responses of Ramos cells expressing the V2 apex-specific CH01.UCA B cell receptor by CAP256 Trimer (orange) and its multimerized (8-mer) form (blue). All Ramos cells were treated with either HIV-1 Env trimer or HIV-1 gp120 antigens and monitored for intracellular Ca2+ binding dye fluorescence for 300s. Ca2+ flux results for the Ramos cells are presented as a percentage of the maximum anti-human IgM or IgG F(ab′) 2 response and are an average of at least two measurements.
N 2 Hydroxyethylpiperazine N 2 Ethane Sulfonic Acid, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2+ap/HEPES%2C+1%2E0M+buffer+soln%2E%2C+pH+6%2E5/pmc13240773-188-19-23
Average 94 stars, based on 1 article reviews
n 2 hydroxyethylpiperazine n 2 ethane sulfonic acid - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
Proteintech anti bcl 2
Effect of multimerization on B cell activation (A) Schematic showing top-down views of HIV-1 Env trimer with binding sites for three different Fabs on the gp120 subunit. 2G12: high mannose glycan clusters, CH31: CD4 binding site, and CH01: targeting quaternary epitope on trimer apex. See also  and  and  .  (B) Calcium flux (Ca2+ flux) responses in Ramos cells expressing CH31 IgM B cell receptors by the monomeric (orange) and tetrameric (blue) forms of B42A monomer. See also  and  .  (C) Activation (Ca2+ flux) of Ramos cells expressing 2G12 IgG B cell receptors by B42A monomer (orange) and tetramer (red) as well as B37B monomer (green) and tetramer (blue). (D) Ca2+ flux responses of Ramos cells expressing the 2G12 IgM B cell receptor by CAP256 Trimer  ,  (orange) and its multimerized (8-mer) form (blue).  (E) Ca2+ flux responses of Ramos cells expressing the V2 apex-specific CH01.UCA B cell receptor by CAP256 Trimer (orange) and its multimerized (8-mer) form (blue). All Ramos cells were treated with either HIV-1 Env trimer or HIV-1 gp120 antigens and monitored for intracellular Ca2+ binding dye fluorescence for 300s. Ca2+ flux results for the Ramos cells are presented as a percentage of the maximum anti-human IgM or IgG F(ab′) 2 response and are an average of at least two measurements.
Anti Bcl 2, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2+ap/OCT4+Antibody/bio_rxiv__64898__2026__10__25__761721-148-69-70
Average 96 stars, based on 1 article reviews
anti bcl 2 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

93
Proteintech polyclonal anti ruvbl1 antibody
a , <t>RUVBL1/2</t> recruits RPAP3 and PIH1D1 to assemble R2TP. By designing binders de novo , we aim to prevent the binding of and/or outcompete RPAP3 from its RUVBL1/2 binding site, thus preventing R2TP assembly. b , Cartoon representation of the RPAP3 binding domain in RUVBL2, highlighting the hydrophobic pocket buried on its ATPase face where RPAP3 inserts residues F630 and M626. c , Iterative binder design strategy. To avoid costly large-scale experimental screening, we aimed to perform de novo design iteratively. Initial designs were strictly filtered in silico , and a limited number of candidates was tested experimentally. Initial binders underwent successive rounds of in silico optimization to improve their affinities. d , Schematic representations of the strategy followed during (i) the first design iteration, RFDiffusion (RFD) was used to generate backbones de novo and ProteinMPNN for inverse folding; (ii) Partial diffusion refinement of binders. RFD was used to add noise to the positions of RB1-A and -B backbones to be denoised into refined backbones, and ProteinMPNN again used for inverse folding; (iii) Sequence Diversity refinement of RB2s. AF2 was used for scoring all designs across all design stages. e , Sorted plot of all K D values from BLI binding characterization of RB3s. Vertical black lines represent average K D values (n=2). f , BLI characterization of the RB3s selected for further characterization, RB3-C, -H and -L.
Polyclonal Anti Ruvbl1 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2+ap/RUVBL1+Antibody/bio_rxiv__64898__2026__10__26__761954-294-18-21
Average 93 stars, based on 1 article reviews
polyclonal anti ruvbl1 antibody - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Proteintech prox1 antibody
a , <t>RUVBL1/2</t> recruits RPAP3 and PIH1D1 to assemble R2TP. By designing binders de novo , we aim to prevent the binding of and/or outcompete RPAP3 from its RUVBL1/2 binding site, thus preventing R2TP assembly. b , Cartoon representation of the RPAP3 binding domain in RUVBL2, highlighting the hydrophobic pocket buried on its ATPase face where RPAP3 inserts residues F630 and M626. c , Iterative binder design strategy. To avoid costly large-scale experimental screening, we aimed to perform de novo design iteratively. Initial designs were strictly filtered in silico , and a limited number of candidates was tested experimentally. Initial binders underwent successive rounds of in silico optimization to improve their affinities. d , Schematic representations of the strategy followed during (i) the first design iteration, RFDiffusion (RFD) was used to generate backbones de novo and ProteinMPNN for inverse folding; (ii) Partial diffusion refinement of binders. RFD was used to add noise to the positions of RB1-A and -B backbones to be denoised into refined backbones, and ProteinMPNN again used for inverse folding; (iii) Sequence Diversity refinement of RB2s. AF2 was used for scoring all designs across all design stages. e , Sorted plot of all K D values from BLI binding characterization of RB3s. Vertical black lines represent average K D values (n=2). f , BLI characterization of the RB3s selected for further characterization, RB3-C, -H and -L.
Prox1 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2+ap/PROX1+Antibody/pmc13748456-119-1-6
Average 94 stars, based on 1 article reviews
prox1 antibody - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
Proteintech o linked n acetylglucosamine transferase ogt antibody
Proposed functional framework linking SERPINA1-associated SOX4–FN1 expression with in vitro LEC responses in PTC. The three modules summarize multi-omics associations, the tumor-cell expression program, and proposed LEC responses. Solid arrows denote experimentally supported expression or phenotypic relationships, whereas dashed arrows denote proposed or inferred connections; neither line style establishes a direct molecular interaction. SOX4 perturbation supports FN1 expression changes, and ChIP-qPCR supports SOX4 occupancy at the assayed FN1 promoter region; neither result establishes direct transcriptional regulation. SOX4 re-expression increased FN1 mRNA and protein levels relative to SERPINA1 knockdown alone ( ; ); phenotypic rescue under this combination remains untested. LEC assays assessed total and phosphorylated NF-κB p65, PROX1 and FLT4/VEGFR3 protein levels and quantified tube-formation and migration responses. The depicted nuclear step, the intervening receptor/signaling mechanisms, and the in vivo lymphangiogenic consequences were not established. Direct <t>OGT-mediated</t> modification of SERPINA1 also remains unresolved. PTC, papillary thyroid carcinoma; LEC, lymphatic endothelial cell; ECM, extracellular matrix; TF, transcription factor; <t>OGT,</t> <t>O-linked</t> <t>N-acetylglucosamine</t> <t>transferase;</t> O-GlcNAc, O-linked N-acetylglucosamine; PLA, proximity ligation assay; co-IP, co-immunoprecipitation; scRNA-seq, single-cell RNA sequencing; ChIP-qPCR, chromatin immunoprecipitation followed by quantitative polymerase chain reaction; NF-κB, nuclear factor κB; VEGFR3, vascular endothelial growth factor receptor 3.
O Linked N Acetylglucosamine Transferase Ogt Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2+ap/OGT+Antibody/pmc13748456-116-1-11
Average 96 stars, based on 1 article reviews
o linked n acetylglucosamine transferase ogt antibody - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Proteintech antibodies against stat1
Proposed functional framework linking SERPINA1-associated SOX4–FN1 expression with in vitro LEC responses in PTC. The three modules summarize multi-omics associations, the tumor-cell expression program, and proposed LEC responses. Solid arrows denote experimentally supported expression or phenotypic relationships, whereas dashed arrows denote proposed or inferred connections; neither line style establishes a direct molecular interaction. SOX4 perturbation supports FN1 expression changes, and ChIP-qPCR supports SOX4 occupancy at the assayed FN1 promoter region; neither result establishes direct transcriptional regulation. SOX4 re-expression increased FN1 mRNA and protein levels relative to SERPINA1 knockdown alone ( ; ); phenotypic rescue under this combination remains untested. LEC assays assessed total and phosphorylated NF-κB p65, PROX1 and FLT4/VEGFR3 protein levels and quantified tube-formation and migration responses. The depicted nuclear step, the intervening receptor/signaling mechanisms, and the in vivo lymphangiogenic consequences were not established. Direct <t>OGT-mediated</t> modification of SERPINA1 also remains unresolved. PTC, papillary thyroid carcinoma; LEC, lymphatic endothelial cell; ECM, extracellular matrix; TF, transcription factor; <t>OGT,</t> <t>O-linked</t> <t>N-acetylglucosamine</t> <t>transferase;</t> O-GlcNAc, O-linked N-acetylglucosamine; PLA, proximity ligation assay; co-IP, co-immunoprecipitation; scRNA-seq, single-cell RNA sequencing; ChIP-qPCR, chromatin immunoprecipitation followed by quantitative polymerase chain reaction; NF-κB, nuclear factor κB; VEGFR3, vascular endothelial growth factor receptor 3.
Antibodies Against Stat1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2+ap/STAT1+Antibody/pm42929875-72-23-26
Average 96 stars, based on 1 article reviews
antibodies against stat1 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
Proteintech anti mlc2v
Proposed functional framework linking SERPINA1-associated SOX4–FN1 expression with in vitro LEC responses in PTC. The three modules summarize multi-omics associations, the tumor-cell expression program, and proposed LEC responses. Solid arrows denote experimentally supported expression or phenotypic relationships, whereas dashed arrows denote proposed or inferred connections; neither line style establishes a direct molecular interaction. SOX4 perturbation supports FN1 expression changes, and ChIP-qPCR supports SOX4 occupancy at the assayed FN1 promoter region; neither result establishes direct transcriptional regulation. SOX4 re-expression increased FN1 mRNA and protein levels relative to SERPINA1 knockdown alone ( ; ); phenotypic rescue under this combination remains untested. LEC assays assessed total and phosphorylated NF-κB p65, PROX1 and FLT4/VEGFR3 protein levels and quantified tube-formation and migration responses. The depicted nuclear step, the intervening receptor/signaling mechanisms, and the in vivo lymphangiogenic consequences were not established. Direct <t>OGT-mediated</t> modification of SERPINA1 also remains unresolved. PTC, papillary thyroid carcinoma; LEC, lymphatic endothelial cell; ECM, extracellular matrix; TF, transcription factor; <t>OGT,</t> <t>O-linked</t> <t>N-acetylglucosamine</t> <t>transferase;</t> O-GlcNAc, O-linked N-acetylglucosamine; PLA, proximity ligation assay; co-IP, co-immunoprecipitation; scRNA-seq, single-cell RNA sequencing; ChIP-qPCR, chromatin immunoprecipitation followed by quantitative polymerase chain reaction; NF-κB, nuclear factor κB; VEGFR3, vascular endothelial growth factor receptor 3.
Anti Mlc2v, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/2+ap/Myosin+Light+Chain+2%2FMLC-2V+Antibody/pmc13710728-281-20-21
Average 94 stars, based on 1 article reviews
anti mlc2v - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

Image Search Results


H&E staining of tumor tissues on day 7 after irradiation: (a) CK group; yellow arrow: densely arranged tumor cells. (b) BNCTN20 group; white arrows: apoptotic cells; red arrow: stromal congestion; black arrow: inflammatory cell infiltration. (c–e) Cleaved caspase-3 immunohistochemical staining and quantitative analysis (brown-yellow indicates positive signal; blue indicates hematoxylin-counterstained nuclei; expressed as IOD/Area).

Journal: bioRxiv

Article Title: BNCT Triggers Immunogenic Cell Death in B16 Melanoma Without Accompanying T-Cell Infiltration—Implications for Combination Immunotherapy

doi: 10.64898/2026.11.04.764456

Figure Lengend Snippet: H&E staining of tumor tissues on day 7 after irradiation: (a) CK group; yellow arrow: densely arranged tumor cells. (b) BNCTN20 group; white arrows: apoptotic cells; red arrow: stromal congestion; black arrow: inflammatory cell infiltration. (c–e) Cleaved caspase-3 immunohistochemical staining and quantitative analysis (brown-yellow indicates positive signal; blue indicates hematoxylin-counterstained nuclei; expressed as IOD/Area).

Article Snippet: After antigen retrieval and blocking, paraffin sections were incubated overnight at 4 °C with the following primary antibodies: anti-CD8α (Abcam, 1:100), anti-granzyme B (Proteintech, 1:50), anti-PD-L1 (Proteintech, 1:100), and anti-cleaved caspase-3 (Proteintech, 1:100), followed by incubation with HRP-conjugated secondary antibodies, DAB chromogenic development, and hematoxylin counterstaining.

Techniques: Staining, Irradiation, Immunohistochemical staining, Analysis

Effect of multimerization on B cell activation (A) Schematic showing top-down views of HIV-1 Env trimer with binding sites for three different Fabs on the gp120 subunit. 2G12: high mannose glycan clusters, CH31: CD4 binding site, and CH01: targeting quaternary epitope on trimer apex. See also  and  and  .  (B) Calcium flux (Ca2+ flux) responses in Ramos cells expressing CH31 IgM B cell receptors by the monomeric (orange) and tetrameric (blue) forms of B42A monomer. See also  and  .  (C) Activation (Ca2+ flux) of Ramos cells expressing 2G12 IgG B cell receptors by B42A monomer (orange) and tetramer (red) as well as B37B monomer (green) and tetramer (blue). (D) Ca2+ flux responses of Ramos cells expressing the 2G12 IgM B cell receptor by CAP256 Trimer  ,  (orange) and its multimerized (8-mer) form (blue).  (E) Ca2+ flux responses of Ramos cells expressing the V2 apex-specific CH01.UCA B cell receptor by CAP256 Trimer (orange) and its multimerized (8-mer) form (blue). All Ramos cells were treated with either HIV-1 Env trimer or HIV-1 gp120 antigens and monitored for intracellular Ca2+ binding dye fluorescence for 300s. Ca2+ flux results for the Ramos cells are presented as a percentage of the maximum anti-human IgM or IgG F(ab′) 2 response and are an average of at least two measurements.

Journal: iScience

Article Title: Anti-HIV-1 B cell antigen receptor structure and signaling

doi: 10.1016/j.isci.2026.118048

Figure Lengend Snippet: Effect of multimerization on B cell activation (A) Schematic showing top-down views of HIV-1 Env trimer with binding sites for three different Fabs on the gp120 subunit. 2G12: high mannose glycan clusters, CH31: CD4 binding site, and CH01: targeting quaternary epitope on trimer apex. See also and and . (B) Calcium flux (Ca2+ flux) responses in Ramos cells expressing CH31 IgM B cell receptors by the monomeric (orange) and tetrameric (blue) forms of B42A monomer. See also and . (C) Activation (Ca2+ flux) of Ramos cells expressing 2G12 IgG B cell receptors by B42A monomer (orange) and tetramer (red) as well as B37B monomer (green) and tetramer (blue). (D) Ca2+ flux responses of Ramos cells expressing the 2G12 IgM B cell receptor by CAP256 Trimer , (orange) and its multimerized (8-mer) form (blue). (E) Ca2+ flux responses of Ramos cells expressing the V2 apex-specific CH01.UCA B cell receptor by CAP256 Trimer (orange) and its multimerized (8-mer) form (blue). All Ramos cells were treated with either HIV-1 Env trimer or HIV-1 gp120 antigens and monitored for intracellular Ca2+ binding dye fluorescence for 300s. Ca2+ flux results for the Ramos cells are presented as a percentage of the maximum anti-human IgM or IgG F(ab′) 2 response and are an average of at least two measurements.

Article Snippet: A positive control stimulant, Anti-human IgM F(ab’) 2 (Jackson Immuno) for the IgM Ramos cell lines or Anti-human IgG F(ab’) 2 (SouthernBiotech) for the IgG cell lines was also included in the antigen plate.

Techniques: Activation Assay, Binding Assay, Glycoproteomics, Expressing, Fluorescence

Affinity, kinetic rates, and signaling comparison of 2G12 IgM and IgG BCRs to HIV-1 Env proteins (A) Reconstruction of 2G12 IgG BCR with gray dotted oval representing the invisible flexible linker and CH31 IgM BCR with colored components. Light chain colored dark blue, heavy chain colored gray, Igα colored green, and Igβ colored orange. (B) Surface plasmon resonance (SPR)-derived dissociation constants (K D , affinity) of HIV-1 Env trimers and monomeric gp120s with 2G12 IgM BCRs (blue) compared with 2G12 IgG BCRs (red). (C) Surface plasmon resonance (SPR)-derived association rates (k a ) (left plot) and dissociation rates (k d ) (right plot) of HIV-1 Env trimers and monomeric gp120s with 2G12 IgM BCRs (blue) compared with 2G12 IgG BCRs (red). All SPR data points are an average of at least three independent measurements. (D) Overlaid surface antigen binding of Ramos cells expressing 2G12 IgM (blue) and 2G12 IgG (red) B cell receptors with multimerized forms of two HIV-1 Env gp120s. Surface binding of tetramerized B37B gp120 is shown in the left plot, and on the right is the binding of tetramerized B42A gp120. Ramos cells expressing either 2G12 IgM or IgG BCRs were incubated with gp120 tetramer and fixed at 0, 0.5, 1, 2, 5, 10, 15, and 30 min time points. Cells were then stained with a fluorophore-conjugated anti-streptavidin antibody for surface binding. (E) Calcium flux (Ca2+ flux) responses over time (s) induced in 2G12 IgM (left) or 2G12 IgG (right) Ramos cells by HIV-1 Env proteins. 2G12 Ramos cells were treated with BG505 GT1.2  ,  (green), CAP256 (red), and CH505TF (blue) trimers at 30 nM or B37B (orange) and B42A gp120 (gray) multimer at 250 nM and monitored for intracellular Ca2+ binding dye fluorescence for 300 s. Ca2+ flux results for the 2G12 Ramos cells are presented as a percentage of the maximum anti-human IgG or IgM F(ab′) 2 response and are an average of at least two measurements. See also  A and S20B.  (F) Comparison of peak Ca2+ flux responses of 2G12 IgM (blue) and 2G12 IgG (red) Ramos cells induced by trimeric HIV-1 Envs and tetramerized gp120 proteins. Maximum Ca2+ flux responses are presented as a percentage of the maximum anti-human IgM or IgG F(ab′) 2 response and are an average with standard deviation of at least two measurements. See also  C.  (G) Comparison of maximum Ca2+ flux responses induced by trimeric versus multimeric forms of HIV-1 gp140 Envs for Ramos cells that express the 2G12 IgG B cell receptor. See also  D. Multimeric forms of both CH505TF  and CAP256  ,  are 8-mers of gp140 trimers, while GT1.2  ,  is a 20-mer of the gp140 trimer. Maximum Ca2+ flux responses are presented as a percentage of the maximum anti-human IgG F(ab′) 2 response and are an average with standard deviation of at least three measurements. See also  and  .

Journal: iScience

Article Title: Anti-HIV-1 B cell antigen receptor structure and signaling

doi: 10.1016/j.isci.2026.118048

Figure Lengend Snippet: Affinity, kinetic rates, and signaling comparison of 2G12 IgM and IgG BCRs to HIV-1 Env proteins (A) Reconstruction of 2G12 IgG BCR with gray dotted oval representing the invisible flexible linker and CH31 IgM BCR with colored components. Light chain colored dark blue, heavy chain colored gray, Igα colored green, and Igβ colored orange. (B) Surface plasmon resonance (SPR)-derived dissociation constants (K D , affinity) of HIV-1 Env trimers and monomeric gp120s with 2G12 IgM BCRs (blue) compared with 2G12 IgG BCRs (red). (C) Surface plasmon resonance (SPR)-derived association rates (k a ) (left plot) and dissociation rates (k d ) (right plot) of HIV-1 Env trimers and monomeric gp120s with 2G12 IgM BCRs (blue) compared with 2G12 IgG BCRs (red). All SPR data points are an average of at least three independent measurements. (D) Overlaid surface antigen binding of Ramos cells expressing 2G12 IgM (blue) and 2G12 IgG (red) B cell receptors with multimerized forms of two HIV-1 Env gp120s. Surface binding of tetramerized B37B gp120 is shown in the left plot, and on the right is the binding of tetramerized B42A gp120. Ramos cells expressing either 2G12 IgM or IgG BCRs were incubated with gp120 tetramer and fixed at 0, 0.5, 1, 2, 5, 10, 15, and 30 min time points. Cells were then stained with a fluorophore-conjugated anti-streptavidin antibody for surface binding. (E) Calcium flux (Ca2+ flux) responses over time (s) induced in 2G12 IgM (left) or 2G12 IgG (right) Ramos cells by HIV-1 Env proteins. 2G12 Ramos cells were treated with BG505 GT1.2 , (green), CAP256 (red), and CH505TF (blue) trimers at 30 nM or B37B (orange) and B42A gp120 (gray) multimer at 250 nM and monitored for intracellular Ca2+ binding dye fluorescence for 300 s. Ca2+ flux results for the 2G12 Ramos cells are presented as a percentage of the maximum anti-human IgG or IgM F(ab′) 2 response and are an average of at least two measurements. See also A and S20B. (F) Comparison of peak Ca2+ flux responses of 2G12 IgM (blue) and 2G12 IgG (red) Ramos cells induced by trimeric HIV-1 Envs and tetramerized gp120 proteins. Maximum Ca2+ flux responses are presented as a percentage of the maximum anti-human IgM or IgG F(ab′) 2 response and are an average with standard deviation of at least two measurements. See also C. (G) Comparison of maximum Ca2+ flux responses induced by trimeric versus multimeric forms of HIV-1 gp140 Envs for Ramos cells that express the 2G12 IgG B cell receptor. See also D. Multimeric forms of both CH505TF and CAP256 , are 8-mers of gp140 trimers, while GT1.2 , is a 20-mer of the gp140 trimer. Maximum Ca2+ flux responses are presented as a percentage of the maximum anti-human IgG F(ab′) 2 response and are an average with standard deviation of at least three measurements. See also and .

Article Snippet: A positive control stimulant, Anti-human IgM F(ab’) 2 (Jackson Immuno) for the IgM Ramos cell lines or Anti-human IgG F(ab’) 2 (SouthernBiotech) for the IgG cell lines was also included in the antigen plate.

Techniques: Comparison, SPR Assay, Derivative Assay, Binding Assay, Expressing, Incubation, Staining, Fluorescence, Standard Deviation

a , RUVBL1/2 recruits RPAP3 and PIH1D1 to assemble R2TP. By designing binders de novo , we aim to prevent the binding of and/or outcompete RPAP3 from its RUVBL1/2 binding site, thus preventing R2TP assembly. b , Cartoon representation of the RPAP3 binding domain in RUVBL2, highlighting the hydrophobic pocket buried on its ATPase face where RPAP3 inserts residues F630 and M626. c , Iterative binder design strategy. To avoid costly large-scale experimental screening, we aimed to perform de novo design iteratively. Initial designs were strictly filtered in silico , and a limited number of candidates was tested experimentally. Initial binders underwent successive rounds of in silico optimization to improve their affinities. d , Schematic representations of the strategy followed during (i) the first design iteration, RFDiffusion (RFD) was used to generate backbones de novo and ProteinMPNN for inverse folding; (ii) Partial diffusion refinement of binders. RFD was used to add noise to the positions of RB1-A and -B backbones to be denoised into refined backbones, and ProteinMPNN again used for inverse folding; (iii) Sequence Diversity refinement of RB2s. AF2 was used for scoring all designs across all design stages. e , Sorted plot of all K D values from BLI binding characterization of RB3s. Vertical black lines represent average K D values (n=2). f , BLI characterization of the RB3s selected for further characterization, RB3-C, -H and -L.

Journal: bioRxiv

Article Title: Disruption of R2TP-mediated PIKK maturation with de novo designed binders

doi: 10.64898/2026.10.26.761954

Figure Lengend Snippet: a , RUVBL1/2 recruits RPAP3 and PIH1D1 to assemble R2TP. By designing binders de novo , we aim to prevent the binding of and/or outcompete RPAP3 from its RUVBL1/2 binding site, thus preventing R2TP assembly. b , Cartoon representation of the RPAP3 binding domain in RUVBL2, highlighting the hydrophobic pocket buried on its ATPase face where RPAP3 inserts residues F630 and M626. c , Iterative binder design strategy. To avoid costly large-scale experimental screening, we aimed to perform de novo design iteratively. Initial designs were strictly filtered in silico , and a limited number of candidates was tested experimentally. Initial binders underwent successive rounds of in silico optimization to improve their affinities. d , Schematic representations of the strategy followed during (i) the first design iteration, RFDiffusion (RFD) was used to generate backbones de novo and ProteinMPNN for inverse folding; (ii) Partial diffusion refinement of binders. RFD was used to add noise to the positions of RB1-A and -B backbones to be denoised into refined backbones, and ProteinMPNN again used for inverse folding; (iii) Sequence Diversity refinement of RB2s. AF2 was used for scoring all designs across all design stages. e , Sorted plot of all K D values from BLI binding characterization of RB3s. Vertical black lines represent average K D values (n=2). f , BLI characterization of the RB3s selected for further characterization, RB3-C, -H and -L.

Article Snippet: For RUVBL1 co-immunoprecipitation, Protein G Dynabeads (Invitrogen) were incubated for 35 min at 25 °C with rotation with polyclonal anti-RUVBL1 antibody (Proteintech #10210-2-AP), washed and equilibrated in lysis buffer.

Techniques: Binding Assay, Screening, In Silico, Diffusion-based Assay, Sequencing

a , Cartoon representation of RB3-H as a representative example of the binders α -helical bundle fold, showing two orthogonal views. b , Surface representation of the raw, refined map of the RUVBL1/2-RB3-H C3-symmetric complex. RB3-H colored in purple, RUVBL1/2 in shades of gray. c , Surface representation of the raw, refined map of the RUVBL1/2-RB3-H complex asymmetric unit after symmetry expansion (left), and cartoon representation of the corresponding atomic model (right). RB3s recognize RUVBL1/2 through two sites. d , Structural details of the RPAP3-RUVBL1/2 interaction in Site 1 (left) and equivalent view of the RUVBL1/2-RB3-H interaction, with RPAP3 M626 and F630 represented as outlines (right). e , Structural details of the RUVBL1/2-RB3-H interaction in Site 2. f , Heatmap of per-residue contacts between binders and RUVBL1/2 with the RB secondary structure indicated schematically on top of the heatmap (left) and bar plot of the number of total interactions (right).

Journal: bioRxiv

Article Title: Disruption of R2TP-mediated PIKK maturation with de novo designed binders

doi: 10.64898/2026.10.26.761954

Figure Lengend Snippet: a , Cartoon representation of RB3-H as a representative example of the binders α -helical bundle fold, showing two orthogonal views. b , Surface representation of the raw, refined map of the RUVBL1/2-RB3-H C3-symmetric complex. RB3-H colored in purple, RUVBL1/2 in shades of gray. c , Surface representation of the raw, refined map of the RUVBL1/2-RB3-H complex asymmetric unit after symmetry expansion (left), and cartoon representation of the corresponding atomic model (right). RB3s recognize RUVBL1/2 through two sites. d , Structural details of the RPAP3-RUVBL1/2 interaction in Site 1 (left) and equivalent view of the RUVBL1/2-RB3-H interaction, with RPAP3 M626 and F630 represented as outlines (right). e , Structural details of the RUVBL1/2-RB3-H interaction in Site 2. f , Heatmap of per-residue contacts between binders and RUVBL1/2 with the RB secondary structure indicated schematically on top of the heatmap (left) and bar plot of the number of total interactions (right).

Article Snippet: For RUVBL1 co-immunoprecipitation, Protein G Dynabeads (Invitrogen) were incubated for 35 min at 25 °C with rotation with polyclonal anti-RUVBL1 antibody (Proteintech #10210-2-AP), washed and equilibrated in lysis buffer.

Techniques: Residue

a , Schematic representation of the competition assay between purified RUVBL1/2-RBD complexes and RBs. Pre-assembled RUVBL1/2-RBD complexes bound to StrepTactin resin are washed with RBs in increasing concentrations and disruption is assessed by the amount of RUVBL1/2 displaced. b , SDS-PAGE analyses of wash fractions from the competition assay depicted in panel a (top) and band intensity quantification (n = 3, each batch of gels processed in parallel) (bottom). c , Effect of RB3-H overexpression on R2TP assembly. Endogenous RUVBL1 was pulled down from HEK293T whole cell lysates transfected with RB3-H-containing or mock plasmids, and the eluates were analyzed by mass spectrometry to quantify the abundance of its partners. The bar plot represents the average and SD of differential abundance of R2TP subunits (n=3). Asterisks indicate p-values from moderated t-tests (limma) adjusted by Benjamini–Hochberg (FDR < 0.05). ns: p > 0.1, **: p < 0.01, ***: p < 0.001. d , Sorted intensity plot of RB3-H interactors (left), with the shaded light-blue region shown magnified (right). RB3-H was overexpressed and pulled down from HEK293T whole cell lysates, and the eluates were analyzed by mass spectrometry. Dots in red indicate proteins significantly detected in endogenous RUVBL1 pull-downs, indicating indirect interaction through RUVBL1, rather than off-target binding of RB3-H.

Journal: bioRxiv

Article Title: Disruption of R2TP-mediated PIKK maturation with de novo designed binders

doi: 10.64898/2026.10.26.761954

Figure Lengend Snippet: a , Schematic representation of the competition assay between purified RUVBL1/2-RBD complexes and RBs. Pre-assembled RUVBL1/2-RBD complexes bound to StrepTactin resin are washed with RBs in increasing concentrations and disruption is assessed by the amount of RUVBL1/2 displaced. b , SDS-PAGE analyses of wash fractions from the competition assay depicted in panel a (top) and band intensity quantification (n = 3, each batch of gels processed in parallel) (bottom). c , Effect of RB3-H overexpression on R2TP assembly. Endogenous RUVBL1 was pulled down from HEK293T whole cell lysates transfected with RB3-H-containing or mock plasmids, and the eluates were analyzed by mass spectrometry to quantify the abundance of its partners. The bar plot represents the average and SD of differential abundance of R2TP subunits (n=3). Asterisks indicate p-values from moderated t-tests (limma) adjusted by Benjamini–Hochberg (FDR < 0.05). ns: p > 0.1, **: p < 0.01, ***: p < 0.001. d , Sorted intensity plot of RB3-H interactors (left), with the shaded light-blue region shown magnified (right). RB3-H was overexpressed and pulled down from HEK293T whole cell lysates, and the eluates were analyzed by mass spectrometry. Dots in red indicate proteins significantly detected in endogenous RUVBL1 pull-downs, indicating indirect interaction through RUVBL1, rather than off-target binding of RB3-H.

Article Snippet: For RUVBL1 co-immunoprecipitation, Protein G Dynabeads (Invitrogen) were incubated for 35 min at 25 °C with rotation with polyclonal anti-RUVBL1 antibody (Proteintech #10210-2-AP), washed and equilibrated in lysis buffer.

Techniques: Competitive Binding Assay, Purification, Disruption, SDS Page, Over Expression, Transfection, Mass Spectrometry, Binding Assay

a , ATP catalytic rates of purified RUVBL1/2 in presence of RPAP3, RBD and RBs. Bars represent average and SD; dots represent individual measurements (n=3-4). b , Comparison of the conformations of RUVBL1/2 ATPase face in ATP-bound (blue shades) and ADP-bound conformations (grey shades). c , BLI association traces for RB3-H binding to immobilized, biotinylated RUVBL1/2 complexes, in buffer supplemented with DMSO, rendering a RUVBL1/2 ADP-bound conformation (left), or ATP and CB-6644, rendering a trapped ATP-bound conformation (right). Dashed lines indicate globally fitted association kinetics. d , Stoichiometry of INO80, TIP60 and SRCAP subunits relative to RUVBL1, comparing an endogenous RUVBL1 immunoprecipitation with RB3-H pull-down. For each protein, log 2 (protein/RUVBL1) was computed per replicate. Δ = mean(RUVBL1 IP) - mean(binder pull-down). Δ > 0 means that, per unit RUVBL1, the protein co-purifies more with endogenous RUVBL1 than with the binder. Bars represent average Δ across three replicates, error bars, SD. Proteins absent from the dataset or detected in < 2 replicates of the RUVBL1 IP were excluded.

Journal: bioRxiv

Article Title: Disruption of R2TP-mediated PIKK maturation with de novo designed binders

doi: 10.64898/2026.10.26.761954

Figure Lengend Snippet: a , ATP catalytic rates of purified RUVBL1/2 in presence of RPAP3, RBD and RBs. Bars represent average and SD; dots represent individual measurements (n=3-4). b , Comparison of the conformations of RUVBL1/2 ATPase face in ATP-bound (blue shades) and ADP-bound conformations (grey shades). c , BLI association traces for RB3-H binding to immobilized, biotinylated RUVBL1/2 complexes, in buffer supplemented with DMSO, rendering a RUVBL1/2 ADP-bound conformation (left), or ATP and CB-6644, rendering a trapped ATP-bound conformation (right). Dashed lines indicate globally fitted association kinetics. d , Stoichiometry of INO80, TIP60 and SRCAP subunits relative to RUVBL1, comparing an endogenous RUVBL1 immunoprecipitation with RB3-H pull-down. For each protein, log 2 (protein/RUVBL1) was computed per replicate. Δ = mean(RUVBL1 IP) - mean(binder pull-down). Δ > 0 means that, per unit RUVBL1, the protein co-purifies more with endogenous RUVBL1 than with the binder. Bars represent average Δ across three replicates, error bars, SD. Proteins absent from the dataset or detected in < 2 replicates of the RUVBL1 IP were excluded.

Article Snippet: For RUVBL1 co-immunoprecipitation, Protein G Dynabeads (Invitrogen) were incubated for 35 min at 25 °C with rotation with polyclonal anti-RUVBL1 antibody (Proteintech #10210-2-AP), washed and equilibrated in lysis buffer.

Techniques: Purification, Comparison, Binding Assay, Immunoprecipitation, Pull Down Assay

a , Immunoblotting detection of mTOR, ATR and TRRAP after transient expression of FLAG-tagged RB3s, compared to controls transfected with mock vector. b , Quantification of panel a, bars represent the mean and vertical lines the SD of the Ponceau-normalized signal expressed relative to the Empty group (dashed line). Overlaid dots represent biological replicates (n=4). The linear axis is shown for interpretability, while significance was calculated on log-transformed values and compared by paired t-tests. *p < 0.05, **p < 0.01, ***p < 0.001. c , Volcano plots obtained by global proteomic analysis of HEK293T overexpressing RB3-H relative to cells transfected with mock vector. R2TP subunits and PIKKs are highlighted. Dashed line indicates p = 0.01. p-values were calculated with moderated t-tests (limma) and adjusted by Benjamini–Hochberg (FDR < 0.05). d , Relative abundance of R2TP subunits and PIKKs averaged across RB3-C, -H and -L overexpression. Bars indicate average log 2 (FC) and standard deviation. e , Functional enrichment analysis of differentially abundant proteins simultaneously identified across RB3-C, -H and -L global proteomics datasets. Genes identified in all three datasets were pooled and classified into pathways by GO-defined biological processes. Differences between RB3 datasets and control conditions were statistically assessed by functional enrichment analysis.

Journal: bioRxiv

Article Title: Disruption of R2TP-mediated PIKK maturation with de novo designed binders

doi: 10.64898/2026.10.26.761954

Figure Lengend Snippet: a , Immunoblotting detection of mTOR, ATR and TRRAP after transient expression of FLAG-tagged RB3s, compared to controls transfected with mock vector. b , Quantification of panel a, bars represent the mean and vertical lines the SD of the Ponceau-normalized signal expressed relative to the Empty group (dashed line). Overlaid dots represent biological replicates (n=4). The linear axis is shown for interpretability, while significance was calculated on log-transformed values and compared by paired t-tests. *p < 0.05, **p < 0.01, ***p < 0.001. c , Volcano plots obtained by global proteomic analysis of HEK293T overexpressing RB3-H relative to cells transfected with mock vector. R2TP subunits and PIKKs are highlighted. Dashed line indicates p = 0.01. p-values were calculated with moderated t-tests (limma) and adjusted by Benjamini–Hochberg (FDR < 0.05). d , Relative abundance of R2TP subunits and PIKKs averaged across RB3-C, -H and -L overexpression. Bars indicate average log 2 (FC) and standard deviation. e , Functional enrichment analysis of differentially abundant proteins simultaneously identified across RB3-C, -H and -L global proteomics datasets. Genes identified in all three datasets were pooled and classified into pathways by GO-defined biological processes. Differences between RB3 datasets and control conditions were statistically assessed by functional enrichment analysis.

Article Snippet: For RUVBL1 co-immunoprecipitation, Protein G Dynabeads (Invitrogen) were incubated for 35 min at 25 °C with rotation with polyclonal anti-RUVBL1 antibody (Proteintech #10210-2-AP), washed and equilibrated in lysis buffer.

Techniques: Western Blot, Expressing, Transfection, Plasmid Preparation, Transformation Assay, Analysis, Over Expression, Standard Deviation, Functional Assay, Proteomic Assay, Control

Proposed functional framework linking SERPINA1-associated SOX4–FN1 expression with in vitro LEC responses in PTC. The three modules summarize multi-omics associations, the tumor-cell expression program, and proposed LEC responses. Solid arrows denote experimentally supported expression or phenotypic relationships, whereas dashed arrows denote proposed or inferred connections; neither line style establishes a direct molecular interaction. SOX4 perturbation supports FN1 expression changes, and ChIP-qPCR supports SOX4 occupancy at the assayed FN1 promoter region; neither result establishes direct transcriptional regulation. SOX4 re-expression increased FN1 mRNA and protein levels relative to SERPINA1 knockdown alone ( ; ); phenotypic rescue under this combination remains untested. LEC assays assessed total and phosphorylated NF-κB p65, PROX1 and FLT4/VEGFR3 protein levels and quantified tube-formation and migration responses. The depicted nuclear step, the intervening receptor/signaling mechanisms, and the in vivo lymphangiogenic consequences were not established. Direct OGT-mediated modification of SERPINA1 also remains unresolved. PTC, papillary thyroid carcinoma; LEC, lymphatic endothelial cell; ECM, extracellular matrix; TF, transcription factor; OGT, O-linked N-acetylglucosamine transferase; O-GlcNAc, O-linked N-acetylglucosamine; PLA, proximity ligation assay; co-IP, co-immunoprecipitation; scRNA-seq, single-cell RNA sequencing; ChIP-qPCR, chromatin immunoprecipitation followed by quantitative polymerase chain reaction; NF-κB, nuclear factor κB; VEGFR3, vascular endothelial growth factor receptor 3.

Journal: Frontiers in Cell and Developmental Biology

Article Title: A SERPINA1-associated SOX4–FN1 epithelial program linked to lymphatic endothelial responses in aggressive papillary thyroid carcinoma

doi: 10.3389/fcell.2026.1929991

Figure Lengend Snippet: Proposed functional framework linking SERPINA1-associated SOX4–FN1 expression with in vitro LEC responses in PTC. The three modules summarize multi-omics associations, the tumor-cell expression program, and proposed LEC responses. Solid arrows denote experimentally supported expression or phenotypic relationships, whereas dashed arrows denote proposed or inferred connections; neither line style establishes a direct molecular interaction. SOX4 perturbation supports FN1 expression changes, and ChIP-qPCR supports SOX4 occupancy at the assayed FN1 promoter region; neither result establishes direct transcriptional regulation. SOX4 re-expression increased FN1 mRNA and protein levels relative to SERPINA1 knockdown alone ( ; ); phenotypic rescue under this combination remains untested. LEC assays assessed total and phosphorylated NF-κB p65, PROX1 and FLT4/VEGFR3 protein levels and quantified tube-formation and migration responses. The depicted nuclear step, the intervening receptor/signaling mechanisms, and the in vivo lymphangiogenic consequences were not established. Direct OGT-mediated modification of SERPINA1 also remains unresolved. PTC, papillary thyroid carcinoma; LEC, lymphatic endothelial cell; ECM, extracellular matrix; TF, transcription factor; OGT, O-linked N-acetylglucosamine transferase; O-GlcNAc, O-linked N-acetylglucosamine; PLA, proximity ligation assay; co-IP, co-immunoprecipitation; scRNA-seq, single-cell RNA sequencing; ChIP-qPCR, chromatin immunoprecipitation followed by quantitative polymerase chain reaction; NF-κB, nuclear factor κB; VEGFR3, vascular endothelial growth factor receptor 3.

Article Snippet: The O-linked N-acetylglucosamine transferase (OGT) antibody was mouse monoclonal, clone 2B2A6 (Proteintech, 66823-1-Ig; reference western blot dilution, 1:10000).

Techniques: Functional Assay, Expressing, In Vitro, Biomarker Discovery, ChIP-qPCR, Knockdown, Migration, In Vivo, Modification, Proximity Ligation Assay, Co-Immunoprecipitation Assay, Single Cell, RNA Sequencing, Chromatin Immunoprecipitation, Real-time Polymerase Chain Reaction